WT1 HLA class II-binding peptides and compositions and methods comprising same

Details for Australian Patent Application No. 2006304573 (hide)

Owner Sloan Kettering Institute for Cancer Research

Inventors Scheinberg, David A.; Pinilla-Ibarz, Javier; May, Rena

Agent Griffith Hack

Pub. Number AU-B-2006304573

PCT Pub. Number WO2007/047764

Priority 60/728,304 20.10.05 US; 60/726,608 17.10.05 US

Filing date 17 October 2006

Wipo publication date 26 April 2007

Acceptance publication date 24 May 2012

International Classifications

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A61K 38/10 (2006.01) Medicinal preparations containing peptides - Peptides having 12 to 20 amino acids

C07K 7/06 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 7/08 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/047764 Priority application(s): WO2007/047764

24 May 2012 Application Accepted

  Published as AU-B-2006304573

20 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006304575-Methods for rejuvenating cells in vitro and in vivo

2006304556-System and method for designing and producing confectionary arrangement